Pfizer’s first quarter results drew a positive market response as management emphasized margin improvement and disciplined ...

Far-right motion relating to pandemic scandal threatens to derail European Commission president’s second-term agenda ...

Pfizer CEO Albert Bourla, Ph.D., has pulled back the curtain on his $1.25 billion bet on a PD-1xVEGF bispecific, revealing ...

Pharma companies met with the Trump administration earlier this month to try and defer implementation of the executive order ...

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert Bourla said on Monday.

Patrick T. Fallon/AFP/Getty Images via CNN Newsource CEO Dr. Albert Bourla says Pfizer has some "very real concerns" about new requirements for clinical trials of Covid-19 vaccines.

Pfizer has promoted Albert Bourla, seen as a likely successor to CEO Ian Read, to the newly-created role of chief operating officer. Move could allow CEO Read to focus on mega-merger.

Britain faces paying more for US drugs as part of a deal to avoid future tariffs from Donald Trump. The NHS will review drug ...

Pfizer and other drug companies met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert Bourla said on Monday. Alex Cohen has ...

“MRNA probably is the most utilized vaccine in the history of humanity,” Pfizer CEO Dr. Albert Bourla said Friday, noting that there have been about 1.5 billion mRNA vaccine doses against ...

CEO Dr. Albert Bourla says Pfizer has some "very real concerns" about new requirements for clinical trials of Covid-19 vaccines. Patrick T. Fallon/AFP/Getty Images via CNN Newsource; ...